Registered entities
Perfuse Therapeutics, Inc
Reg. No. 833240662United States
Innovation
6 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 263 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 1 |
Social engagement
Social engagement: 2K social following, 9 posts in the last 12 months — top quartile of its industry.
Investor mix
5 investors on record; lead investors include Access Industries.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |
Recent activity
15 Oct 2025
Event
OIS XV
13 Oct 2025
Event
Eyecelerator @ AAO 2025